KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Petmed Express (PETS) Change in Receivables (2016 - 2025)

Petmed Express' Change in Receivables history spans 16 years, with the latest figure at -$425000.0 for Q4 2025.

  • For Q4 2025, Change in Receivables fell 153.93% year-over-year to -$425000.0; the TTM value through Dec 2025 reached -$672000.0, down 172.81%, while the annual FY2025 figure was -$601000.0, 134.5% down from the prior year.
  • Change in Receivables reached -$425000.0 in Q4 2025 per PETS's latest filing, down from $372000.0 in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $1.6 million in Q1 2024 to a low of -$880000.0 in Q2 2024.
  • Average Change in Receivables over 5 years is $35200.0, with a median of -$128500.0 recorded in 2022.
  • The largest YoY upside for Change in Receivables was 673.5% in 2024 against a maximum downside of 2013.04% in 2024.
  • A 5-year view of Change in Receivables shows it stood at -$541000.0 in 2021, then skyrocketed by 207.39% to $581000.0 in 2022, then crashed by 138.9% to -$226000.0 in 2023, then skyrocketed by 448.67% to $788000.0 in 2024, then tumbled by 153.93% to -$425000.0 in 2025.
  • Per Business Quant, the three most recent readings for PETS's Change in Receivables are -$425000.0 (Q4 2025), $372000.0 (Q3 2025), and -$718000.0 (Q2 2025).